跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,616 条关于
“TNX-4900”
全部
2,616
临床试验
1,786
药物
664
机构
12
资讯
154
9个月前
Tonix Pharmaceuticals Licenses TNX-4900, Novel Sigma-1 Receptor Antagonist for Chronic Neuropathic Pain
去年
Tonix Pharmaceuticals Licenses Long-Acting Monoclonal Antibody TNX-4800 for Seasonal Lyme Disease Prevention
5个月前
Tonix Pharmaceuticals Initiates Phase 1 Study of TNX-1900 Intranasal Oxytocin for Migraine Treatment
8个月前
Tonix Pharmaceuticals Advances TNX-4800 Monoclonal Antibody for Lyme Disease Prevention with FDA Meeting Planned for 2026
11个月前
Tonix Pharmaceuticals Advances TNX-2900 to Phase 2 Trial for Prader-Willi Syndrome Following FDA Clearance
2年前
Tonix Pharmaceuticals Presents Promising Data on Mpox Vaccine Candidate TNX-801
去年
Tonix Pharmaceuticals' TNX-102 SL Shows Promise in Fibromyalgia Treatment
去年
Tonix Pharmaceuticals Submits NDA for TNX-102 SL in Fibromyalgia
11个月前
Tonix Pharmaceuticals Advances TNX-1500 Anti-CD40L Antibody for Transplant Rejection Prevention
去年
Tonix Pharmaceuticals Submits NDA for TNX-102 SL for Fibromyalgia Treatment
第 1 页,共 16 页
上一页
下一页